Gene synthesis companies establish measures to counter bioterrorism
By European Biotechnology Science and Industry News,
European Biotechnology Science and Industry News
| 11. 20. 2009
The five largest suppliers of synthetic DNA will establish common measures to prevent misuse of synthetically produced DNA by bioterorrists or criminals. Yesterday, Blue Heron Biotechnology, DNA2.0, GENEART, GenScript and Integrated DNA Technologies, which together represent an 80% share of the synthetic DNA market, announced the establishment of a common screening protocol that will be applied to every single synthetic gene order. "We are proud to announce the formation of the International Gene Synthesis Consortium", said John Mulligan, CSO of Blue Heron Biotechnology.
The IGSC's "Harmonized Screening Protocol" is comprised of the screening of gene sequences against a regulated pathogen database developed by the consortium and one or more of the internationally coordinated sequence reference databanks, such as NCBI/GenBank, EBI/EMBL, or DDBJ. Amino acid sequences of possible translation products for each ordered synthetic gene will also be screened. Purchasers of synthetic genes will also be screened in accordance with national guidelines. Furthermore, the IGSC companies have agreed to keep all screening, customer, and order records for at least eight years. IGSC companies have also reserved the right to refuse to...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...
By Charmayne Allison, ABC News | 09.21.2025
It has been seven years since Chinese biophysicist He Jiankui made an announcement that shocked the world's scientists.
He had made the world's first gene-edited babies.
Through rewriting DNA in twin girls' embryos, the man who would later be dubbed...